SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
06-Jun-24 4:25 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Jun-24 | Grant | 150,647 | -- | -- | 315% 47.84K to 198.49K | |
18-Aug-23 6:31 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 17-Aug-23 | Option Exercise | 41,949 | $0.75 | $31,519.30 | 100% 0 to 41.95K | |
18-Aug-23 6:31 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 17-Aug-23 | Planned Option Sale | 41,949 | $6.49 | $272,334.00 | (100%) 41.95K to 0 | |
05-Jun-23 4:33 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Jun-23 | Grant | 32,362 | -- | -- | 209% 15.48K to 47.84K | |
19-Jul-22 5:16 PM View: | Cara Therapeutics, Inc. (CARA) | 15-Jul-22 | Sale (Planned) | 3,600 | $9.05 | $32,580.00 | (19%) 19.08K to 15.48K | |
06-Jun-22 5:51 PM View: | Cara Therapeutics, Inc. (CARA) | 02-Jun-22 | Grant | 11,876 | -- | -- | 165% 7.2K to 19.08K | |
16-Nov-21 6:15 PM View: | Cara Therapeutics, Inc. (CARA) | 12-Nov-21 | Market Sale | 8,180 | $16.04 | $131,207.00 | (53%) 15.38K to 7.2K | 2% |
07-Jun-21 7:25 PM View: | Cara Therapeutics, Inc. (CARA) | 07-Jun-21 | Market Sale (Planned) | 2,520 | $13.05 | $32,886.00 | (14%) 17.9K to 15.38K | |
07-Jun-21 7:25 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Jun-21 | Grant | 7,200 | -- | -- | 67% 10.7K to 17.9K | |
23-Nov-20 8:26 PM View: | Cara Therapeutics, Inc. (CARA) | 19-Nov-20 | Grant | 2,500 | $15.75 | $39,372.50 | 30% 8.2K to 10.7K | (< 1%) |
08-Jun-20 5:47 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Jun-20 | Grant | 7,200 | -- | -- | 120% 6.0K to 13.2K | |
03-Jun-20 7:51 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Jun-20 | Option Exercise | 1,000 | $9.94 | $9,940.00 | 17% 6.0K to 7.0K | |
03-Jun-20 7:51 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Jun-20 | Market Option Sale (Planned) | 1,000 | $16.00 | $16,000.00 | (14%) 7.0K to 6.0K | 2% |
14-May-20 8:02 PM View: | Cara Therapeutics, Inc. (CARA) | 12-May-20 | Option Exercise | 2,500 | $9.94 | $24,850.00 | 42% 6.0K to 8.5K | |
14-May-20 8:02 PM View: | Cara Therapeutics, Inc. (CARA) | 12-May-20 | Market Option Sale (Planned) | 2,500 | $16.00 | $40,000.00 | (29%) 8.5K to 6.0K | 2% |
21-Apr-20 7:09 PM View: | Cara Therapeutics, Inc. (CARA) | 21-Apr-20 | Option Exercise | 2,500 | $9.94 | $24,850.00 | 42% 6.0K to 8.5K | |
21-Apr-20 7:09 PM View: | Cara Therapeutics, Inc. (CARA) | 21-Apr-20 | Market Option Sale (Planned) | 2,500 | $16.00 | $40,000.00 | (29%) 8.5K to 6.0K | 2% |
06-Mar-20 4:39 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Mar-20 | Option Exercise | 2,500 | $9.94 | $24,850.00 | 42% 6.0K to 8.5K | |
06-Mar-20 4:39 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Mar-20 | Market Option Sale (Planned) | 2,500 | $16.00 | $40,000.00 | (29%) 8.5K to 6.0K | 2% |
05-Feb-20 5:01 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Feb-20 | Option Exercise | 2,500 | $9.94 | $24,850.00 | 42% 6.0K to 8.5K | |
05-Feb-20 5:01 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Feb-20 | Market Option Sale (Planned) | 2,500 | $16.23 | $40,575.00 | (29%) 8.5K to 6.0K | 3% |
06-Jan-20 6:06 PM View: | Cara Therapeutics, Inc. (CARA) | 02-Jan-20 | Option Exercise | 2,500 | $9.94 | $24,850.00 | 42% 6.0K to 8.5K | |
06-Jan-20 6:06 PM View: | Cara Therapeutics, Inc. (CARA) | 02-Jan-20 | Market Option Sale (Planned) | 2,500 | $16.13 | $40,325.00 | (29%) 8.5K to 6.0K | 3% |
04-Dec-19 7:49 PM View: | Cara Therapeutics, Inc. (CARA) | 02-Dec-19 | Option Exercise | 2,500 | $5.32 | $13,300.00 | 42% 6.0K to 8.5K | |
04-Dec-19 7:49 PM View: | Cara Therapeutics, Inc. (CARA) | 02-Dec-19 | Market Option Sale (Planned) | 2,500 | $25.83 | $64,575.00 | (29%) 8.5K to 6.0K | 39% |
05-Nov-19 6:21 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Nov-19 | Option Exercise | 2,500 | $5.32 | $13,300.00 | 42% 6.0K to 8.5K | |
05-Nov-19 6:21 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Nov-19 | Market Option Sale (Planned) | 2,500 | $20.68 | $51,700.00 | (29%) 8.5K to 6.0K | 24% |
03-Oct-19 9:19 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Oct-19 | Option Exercise | 2,500 | $5.32 | $13,300.00 | 42% 6.0K to 8.5K | |
03-Oct-19 9:19 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Oct-19 | Market Option Sale (Planned) | 2,500 | $18.21 | $45,525.00 | (29%) 8.5K to 6.0K | 14% |
05-Sep-19 5:37 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Sep-19 | Option Exercise | 2,500 | $5.32 | $13,300.00 | 42% 6.0K to 8.5K | |
05-Sep-19 5:37 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Sep-19 | Market Option Sale (Planned) | 2,500 | $23.31 | $58,275.00 | (29%) 8.5K to 6.0K | 33% |
05-Aug-19 5:32 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Aug-19 | Option Exercise | 2,500 | $5.32 | $13,300.00 | 42% 6.0K to 8.5K | |
05-Aug-19 5:32 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Aug-19 | Market Option Sale (Planned) | 2,500 | $23.24 | $58,100.00 | (29%) 8.5K to 6.0K | 32% |
03-Jul-19 4:04 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Jul-19 | Option Exercise | 2,500 | $5.32 | $13,300.00 | 42% 6.0K to 8.5K | |
03-Jul-19 4:04 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Jul-19 | Market Option Sale (Planned) | 2,500 | $21.75 | $54,375.00 | (29%) 8.5K to 6.0K | 28% |
06-Jun-19 6:01 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Jun-19 | Grant | 6,000 | -- | -- | 100% 0 to 6.0K |